AUPH - Aurinia Pharmaceuticals Inc. (AUPH) CEO Peter Greenleaf on Q4 2020 Results - Earnings Call Transcript
Aurinia Pharmaceuticals Inc. (AUPH) Q4 2020 Earnings Conference Call February 24, 2021 16:30 ET Company Participants Glenn Schulman - Senior Vice President, Investor Relations Peter Greenleaf - President and Chief Executive Officer Neil Solomons - Chief Medical Officer Max Colao - Chief Commercial Officer Joe Miller - Chief Financial Officer Conference Call Participants Ken Cacciatore - Cowen & Company Maury Raycroft - Jefferies Justin Kim - Oppenheimer David Martin - Bloom Burton Ed Arce - H.C. Wainwright Presentation Operator Greetings and welcome to the Aurinia Year End 2020 Financial Results Conference Call. [Operator Instructions] It’s now my pleasure to turn the call over to Glenn Schulman, Senior Vice President, Investor Relations. Please go ahead, sir. Glenn Schulman Thank you, Kevin and good afternoon everyone. I am pleased to welcome you to today’s call discussing Aurinia’s fourth quarter and year end financial results. Joining me on the call this afternoon are
For further details see:
Aurinia Pharmaceuticals Inc. (AUPH) CEO Peter Greenleaf on Q4 2020 Results - Earnings Call Transcript